Embecta Corp.

embecta to Participate in Investor Events

Embecta management is scheduled to participate in the Wells Fargo 2026 Healthcare Conference on September 9 in Boston, hosting one-on-one investor meetings. The company will also attend the J.P. Morgan 4th Annual Nashville Healthcare Conference on September 10, which will include a fireside chat and additional one-on-one meetings. Embecta is a global medical supplies company focused on advancing a 100-year legacy in insulin delivery.

•2mo ago

Lifshitz Law PLLC Announces Investigations of Futu Holding Limited (NASDAQ: FUTU), Peabody Energy Corporation (NYSE: BTU), Embecta Corp. (NASDAQ: EMBC), and Black Rock Coffee Bar, Inc. (NASDAQ: BRCB)

Lifshitz Law PLLC announced an investigation into Black Rock Coffee Bar regarding potential securities law violations and breaches of fiduciary duty. The firm alleges that new store openings are cannibalizing existing revenue and that the company overstated the effectiveness of its expansion strategy to avoid 'sales transfer'. Investors are being solicited to contact the law firm to discuss their rights.

•2mo ago

EMBC Stock News: Embecta Sued for Securities Fraud over Alleged Misrepresentations and Corresponding 57% Stock Drop

Bleichmar Fonti & Auld LLP announced a securities fraud class action lawsuit against Embecta Corp., alleging the company misled investors regarding the strength of its insulin pen needle product category. The lawsuit follows a 57.8% stock drop on May 5, 2026, after Embecta reported disappointing Q2 results, cited share loss, and cut its dividend. The firm is soliciting investors to serve as lead plaintiff by the August 17, 2026 deadline.

•2mo ago

Embecta Corp. Sued for Securities Law Violations - FINAL DEADLINE TODAY - EMBC

DJS Law Group issued a reminder regarding the lead plaintiff deadline for a class action lawsuit against Embecta Corp. The complaint alleges Embecta made false statements about pen needle market challenges and the reliability of its fiscal guidance. This is a plaintiff-firm solicitation urging shareholders to contact them by the August 17, 2026 deadline.

•2mo ago

EMBC Investor Announcement: Embecta Sued on behalf of Investors to Recover Losses after Insulin Pen Issues Lead to 57% Stock Drop

Bleichmar Fonti & Auld LLP announced it filed a class action lawsuit against Embecta Corp. on behalf of investors alleging securities fraud. The lawsuit follows a 57.8% stock drop on May 5, 2026, triggered by disappointing Q2 results and a dividend cut from $0.15 to $0.01 per share. This release is a solicitation for investors to seek lead plaintiff status before the August 17, 2026 deadline.

•2mo ago

Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results

Embecta reported third quarter fiscal 2026 financial results, though the specific financial metrics and performance details are contained in a separate release linked in the text. The company will host a conference call and live audio webcast today at 8:00 a.m. ET to discuss the results, with a replay available on its investor relations website. Embecta describes its strategy as leveraging a 100-year legacy in insulin delivery to expand into a broad-based medical supplies company.

•3mo ago

embecta Announces Quarterly Cash Dividend

Embecta's Board of Directors declared a quarterly cash dividend of $0.01 per share on the company's issued and outstanding common stock. The dividend is payable on September 15, 2026 to stockholders of record at the close of business on August 27, 2026.

•3mo ago